Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.36 |
| ▸ | MGAM | O43451 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14369584 | 0.85 | ESR1 (0.42) | MAPTESR1ESR2NR1H2NR1H3 | |
| SCHEMBL12191013 | 0.83 | ESR1 (0.41) | MAPTESR1ESR2TP53NR1H2 | |
| SCHEMBL9217667 | 0.80 | MAPT (0.47) | MAPTESR1ESR2TP53NR1H2 | |
| SCHEMBL12879487 | 0.79 | MAPT (0.42) | MAPTESR1ESR2TP53NR1H2 | |
| SCHEMBL15857807 | 0.79 | NR1H2 (0.33) | MAPTESR1ESR2NR1H2NR1H3 | |
| SCHEMBL2329848 | 0.78 | NR1H2 (0.47) | MAPTESR1ESR2TP53NR1H2 | |
| SCHEMBL17721362 | 0.78 | NR1H2 (0.38) | MAPTESR1ESR2NR1H2NR1H3 | |
| Water SCHEMBL28197942 | 0.77 | MAPT (0.41) | MAPTESR1ESR2TP53NR1H2 | |
| SCHEMBL988676 | 0.77 | NR1H2 (0.43) | MAPTESR1ESR2TP53NR1H2 | |
| Sorbic Acid SCHEMBL28861239 | 0.76 | MAPT (0.49) | MAPTESR1ESR2PTGS2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200112057-A1 | ALKALI ION CONDUCTING PLASTIC CRYSTALS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2020-04-09 | — | — | US | claimed |
| US-20190020060-A1 | ALKALI ION CONDUCTING PLASTIC CRYSTALS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2019-01-17 | — | — | US | claimed |
| CN-101074240-B | Synthesis of P-bi(dimethyl-ethyl-silicone) benzene by sodium condensation | HUAYE MEDICAL CHEMICAL CO LTD YANCHENG | 2010-12-22 | — | — | CN | claimed |
| CN-101074240-A | Synthesis of P-bi(dimethyl-ethyl-silicone) benzene by sodium condensation | HUAYE MEDICAL CHEMICAL CO LTD (CN) | 2007-11-21 | — | — | CN | claimed |
| US-12100804-B2 | Alkali ION conducting plastic crystals | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2024-09-24 | — | — | US | disclosed |
| US-20240120532-A1 | Alkali ION Conducting Plastic Crystals | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2024-04-11 | — | — | US | disclosed |
| US-20230212207-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-06 | — | — | US | disclosed |
| US-11695153-B2 | Alkali ion conducting plastic crystals | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-07-04 | — | — | US | disclosed |
| US-20230200102-A1 | MIXED LAYER, METHOD OF PREPARING THE MIXED LAYER, LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20220123360-A1 | ALKALI ION CONDUCTING PLASTIC CRYSTALS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2022-04-21 | — | — | US | disclosed |
| US-11094963-B2 | Alkali ion conducting plastic crystals | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2021-08-17 | — | — | US | disclosed |
| CN-111033862-A | Method for inhibiting decomposition of silyl ester compound | 株式会社艾迪科 | 2020-04-17 | — | — | CN | disclosed |
| EP-0320211-B1 | PROCESS FOR PRODUCING A TETRACARBOXYLIC ACID ANHYDRIDE HAVING DISILOXANE LINKAGE | Hitachi Chemical Co., Ltd. (JP) | 1993-06-16 | — | — | EP | disclosed |
| US-5166363-A | Process for producing 1,3-bis(dicarboxyphenyl)-disiloxane derivative or dianhydride thereof | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1992-11-24 | — | — | US | disclosed |
| US-5151538-A | ORGANOSILICON COMPOUND AND PROCESS FOR PRODUCING ORGANOSILICON COMPOUND | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1992-09-29 | — | — | US | disclosed |
| EP-0473658-A1 | THERMAL INSULATION | F. WILLICH GMBH &CO.. (DE) | 1992-03-11 | — | — | EP | disclosed |
| WO-1990014553-A1 | THERMAL INSULATION | F. WILLICH GMBH & CO. (DE) | 1990-11-29 | — | — | WO | disclosed |
| EP-0378430-A1 | Novel organosilicon compound and process for producing organosilicon compound | DIRECTOR-GENERAL OF THE AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1990-07-18 | — | — | EP | disclosed |
| EP-0320211-A2 | Process for producing a tetracarboxylic acid anhydride having disiloxane linkage | Hitachi Chemical Co., Ltd. (JP) | 1989-06-14 | — | — | EP | disclosed |
| EP-0292260-A2 | Process for producing 1,3-bis(dicarboxyphenyl)-disiloxane derivative or dianhydride thereof | Hitachi Chemical Co., Ltd. (JP) | 1988-11-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212207-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OTC, OCIAD1 | MAPT 803/4885ESR1 465/4885ESR2 521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.